• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HE Yuanzi,ZHANG Lei,WU Chunyong,ZHANG Junying.Application of three-dimensional models in prediction of drug-induced hepatotoxicity[J].Journal Of Pharmaceutical Research,2021,40(10):678-683[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2391times   Download 2749次 QR Code for this article
Scan with your phone!
体外三维肝细胞模型在药物肝毒性评价中的应用
何原子1,2,张雷3,吴春勇1,2,张峻颖4
Font:Larger+|Default|Smaller-
(1.中国药科大学药物质量与安全预警教育部重点实验室,江苏 南京 210009;2.中国药科大学药物分析教研室,江苏 南京 211198;3.山东省食品药品检验研究院,山东 济南 250101;4.中国药科大学中药制剂教研室,江苏 南京 211198)
摘要:
肝毒性是药物治疗过程中常见的副作用,也是导致新药临床试验失败以及药物撤市的主要原因。建立可以有效识别药物肝毒性的体外模型对于新药研发至关重要。传统的二维(2D)模型在培养过程中会逐渐丧失肝脏特异性功能,无法准确评价药物肝毒性。新兴的三维(3D)培养技术可模拟体内细胞微环境,有利于肝细胞的体外组装,从而使3D肝细胞模型表现出与体内肝细胞相似的表型以及药物毒性反应,在肝毒性评价方面具有很大潜力。
关键词:  3D模型  肝毒性  3D细胞培养  药物筛选
DOI:10.13506/j.cnki.jpr.2021.10.012
基金项目:国家自然科学基金(No.82074128、81673681);江苏省市场监督管理局科技计划项目(No.KJ207558);国家药品家督管理局化学药品杂质谱研究重点实验室开放课题(No.NMPA-KLIPCD-2020-01)
Publication Date:October 25, 2021
Application of three-dimensional models in prediction of drug-induced hepatotoxicity
HE Yuanzi1,2,ZHANG Lei3,WU Chunyong1,2,ZHANG Junying4
(1.Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China; 2.Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 211198, China; 3.Shandong Institute for Food and Drug Control 250101, China; 4.Department of Pharmaceutics of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Hepatotoxicity is a common side effect during drug treatment, and also the main reason for the failure of clinical trials and the withdrawal of drugs from the market. Therefore, it is crucial to develop an in vitro model that could effectively identify the drug hepatotoxicity for the new drug research and development. However, traditional hepatocyte models are limited due to the loss of the specific liver functions during two-dimensional (2D) culture, thus failing to accurately evaluate the hepatotoxicity. The emerging three-dimensional (3D) culture technology provides benefits for the in vitro assemble of hepatocytes by simulating the physiological microenvironment. Therefore, 3D hepatocytes could exhibit in vivo-like phenotypes and reactions to drug toxicity and have great potential in the evaluation of hepatotoxicity.
Key words:  3D model  Hepatotoxicity  3D cell culture  Drug screening
Today's Visits:463    Total Visits:2383158
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.